Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis
Embodiments of screening methods for determining test agents effective for modifying the appearance of pigmented skin are provided. The screening method may comprise the steps of contacting a cell, a cell culture, or bulk cells with the test agent, wherein the cell, the cell culture, or the bulk cells comprise ADRβ1 receptors, and determining based on the binding interaction of the test agent with the ADRβ1 receptors whether the test agent is an effective ADRβ1 receptor antagonist suitable for modifying the appearance of pigmented skin, wherein a test agent is considered to be an effective ADRβ1 receptor antagonist when it defines a half maximal inhibitory concentration of less than about 1000 ppm.
The Procter & Gamble Company
G G
G01N G01N
additional inventional
John Crist Leo Timothy Tomohiro Jiazhen Wenzhu
Bierman Laughlin, II Hakozaki Wang Zhao